| CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy R Tokunaga, WU Zhang, M Naseem, A Puccini, MD Berger, S Soni, ... Cancer treatment reviews 63, 40-47, 2018 | 1012 | 2018 |
| Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers ME Salem, A Puccini, A Grothey, D Raghavan, RM Goldberg, J Xiu, ... Molecular Cancer Research 16 (5), 805-812, 2018 | 216 | 2018 |
| Outlooks on Epstein-Barr virus associated gastric cancer M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ... Cancer treatment reviews 66, 15-22, 2018 | 201 | 2018 |
| B cell and B cell-related pathways for novel cancer treatments R Tokunaga, M Naseem, JH Lo, F Battaglin, S Soni, A Puccini, MD Berger, ... Cancer treatment reviews 73, 10-19, 2019 | 159 | 2019 |
| Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma ME Salem, A Puccini, J Xiu, D Raghavan, HJ Lenz, WM Korn, AF Shields, ... The oncologist 23 (11), 1319-1327, 2018 | 149 | 2018 |
| Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors ME Salem, JN Bodor, A Puccini, J Xiu, RM Goldberg, A Grothey, WM Korn, ... International journal of cancer 147 (10), 2948-2956, 2020 | 105 | 2020 |
| Safety and tolerability of c-MET inhibitors in cancer A Puccini, NI Marín-Ramos, F Bergamo, M Schirripa, S Lonardi, HJ Lenz, ... Drug safety 42, 211-233, 2019 | 97 | 2019 |
| Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer R Tokunaga, J Xiu, C Johnston, RM Goldberg, PA Philip, A Seeber, ... Clinical Cancer Research 25 (10), 3096-3103, 2019 | 81 | 2019 |
| Molecular profile of BRCA-mutated biliary tract cancers G Spizzo, A Puccini, J Xiu, RM Goldberg, A Grothey, AF Shields, SP Arora, ... Esmo Open 5 (3), e000682, 2020 | 78 | 2020 |
| Colorectal cancer: epigenetic alterations and their clinical implications A Puccini, MD Berger, M Naseem, R Tokunaga, F Battaglin, S Cao, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 439-448, 2017 | 78 | 2017 |
| Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) A Puccini, K Poorman, ME Salem, D Soldato, A Seeber, RM Goldberg, ... Clinical Cancer Research 26 (22), 5943-5951, 2020 | 72 | 2020 |
| Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions F Battaglin, M Naseem, A Puccini, HJ Lenz Cancer Cell International 18, 1-18, 2018 | 70 | 2018 |
| Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers ME Salem, SM El-Refai, W Sha, A Puccini, A Grothey, TJ George, ... JCO Precision Oncology 6, e2100245, 2022 | 55 | 2022 |
| The role of tumor angiogenesis as a therapeutic target in colorectal cancer F Battaglin, A Puccini, R Intini, M Schirripa, A Ferro, F Bergamo, S Lonardi, ... Expert review of anticancer therapy 18 (3), 251-266, 2018 | 55 | 2018 |
| The impact of ARID1A mutation on molecular characteristics in colorectal cancer R Tokunaga, J Xiu, RM Goldberg, PA Philip, A Seeber, F Battaglin, H Arai, ... European Journal of Cancer 140, 119-129, 2020 | 44 | 2020 |
| Impact of patient age on molecular alterations of left‐sided colorectal tumors A Puccini, HJ Lenz, JL Marshall, D Arguello, D Raghavan, WM Korn, ... The oncologist 24 (3), 319-326, 2019 | 43 | 2019 |
| Management of advanced small bowel cancer A Puccini, F Battaglin, HJ Lenz Current treatment options in oncology 19, 1-14, 2018 | 37 | 2018 |
| Practice-changing updates in the adjuvant and metastatic setting A Puccini, HJ Lenz Nature Reviews Clinical Oncology 15 (2), 77-78, 2018 | 35 | 2018 |
| Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies A Puccini, F Battaglin, ML Iaia, HJ Lenz, ME Salem Journal for Immunotherapy of Cancer 8 (1), 2020 | 34 | 2020 |
| The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer F Battaglin, A Puccini, S Ahcene Djaballah, HJ Lenz Cancer management and research, 5911-5924, 2019 | 32 | 2019 |
Heinz-Josef LenzUniversity of Southern CalifforniaBestätigte E-Mail-Adresse bei usc.edu
